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1  | INTRODUC TION
The English physician Thomas Sydenham (1624–1689) once noted 
that “a man is as old as his arteries” (Ungvari, 2015). Today, we know 
that age is an independent risk factor for atherosclerosis as well as 
secondary diseases such as myocardial infarction and stroke (Wang 
& Bennett, 2012) that represent the main cause of death worldwide 
(Gisterå & Hansson, 2017). Therefore, understanding the processes 
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Abstract
Aging	is	an	independent	risk	factor	for	cardiovascular	diseases	and	therefore	of	par‐
ticular interest for the prevention of cardiovascular events. However, the mecha‐
nisms underlying vascular aging are not well understood. Since carcinoembryonic 
antigen‐related	cell	adhesion	molecule	1	(CEACAM1)	is	crucially	involved	in	vascular	
homeostasis,	we	sought	 to	 identify	 the	 role	of	CEACAM1	 in	vascular	aging.	Using	
human	internal	thoracic	artery	and	murine	aorta,	we	show	that	CEACAM1	is	upregu‐
lated	in	the	course	of	vascular	aging.	Further	analyses	demonstrated	that	TNF‐α is 
CEACAM1‐dependently	upregulated	in	the	aging	vasculature.	Vice	versa,	TNF‐α in‐
duces	CEACAM1	expression.	This	results	in	a	feed‐forward	loop	in	the	aging	vascula‐
ture	that	maintains	a	chronic	pro‐inflammatory	milieu.	Furthermore,	we	demonstrate	
that	age‐associated	vascular	alterations,	that	is,	increased	oxidative	stress	and	vascu‐
lar fibrosis, due to increased medial collagen deposition crucially depend on the pres‐
ence	of	CEACAM1.	Additionally,	age‐dependent	upregulation	of	vascular	CEACAM1	
expression	 contributes	 to	 endothelial	 barrier	 impairment,	 putatively	 via	 increased	
VEGF/VEGFR‐2	 signaling.	 Consequently,	 aging‐related	 upregulation	 of	 vascular	
CEACAM1	expression	results	in	endothelial	dysfunction	that	may	promote	athero‐
sclerotic	plaque	formation	in	the	presence	of	additional	risk	factors.	Our	data	suggest	
that	CEACAM1	might	represent	an	attractive	target	in	order	to	delay	physiological	
aging and therefore the transition to vascular disorders such as atherosclerosis.
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of vascular aging is of greatest significance to prevent the onset of 
cardiovascular diseases. However, compared to pathological condi‐
tions such as atherosclerosis, physiological vascular aging is less well 
understood (Xu et al., 2017).
On the macroscopic level, aging alters the mechanical proper‐
ties of blood vessels by increasing vascular stiffness. This is due to 
a reduced content of elastic fibers, but increased vascular collagen 
deposition,	 calcification,	 and	 intimal	 thickening	 (Collins,	 Munoz,	
Patel,	Loukas	&	Tubbs,	2014;	Tonar	et	al.,	2015).	Intimal	thickening	
is present in older people even in populations with low incidence 
of	atherosclerosis	(Virmani	et	al.,	1991)	and	predicts	cardiovascular	
events (Okayama et al., 2013).
Besides these macroscopic alterations, aging is associated with 
a	shift	toward	a	pro‐inflammatory	milieu.	This	is	illustrated	by	the	
finding	that	the	level	of	TNF‐α,	a	very	important	pro‐inflammatory	
mediator, is elevated in serum as well as in the vasculature of aging 
humans and rodents (Csiszar, Ungvari, Koller, Edwards & Kaley, 
2003; Paolisso et al., 1998; Spaulding, Walford & Effros, 1997). 
Age‐dependent	inflammation	is	associated	with	increased	vascu‐
lar	oxidative	stress	and	contributes	to	the	development	of	endo‐
thelial	dysfunction	(ED)	(Rodríguez‐Mañas	et	al.,	2009).	Since	ED	
may initiate vascular disorders such as atherosclerosis (Bömmel 
et	 al.,	 2017;	 Dantas,	 Jiménez‐Altayó	 &	 Vila,	 2012;	 Rodríguez‐
Mañas	et	 al.,	 2009),	ED	 links	physiological	 aging	 to	 the	onset	of	
pathological processes. Furthermore, ED predicts cardiovascular 
events	in	humans	(Gokce	et	al.,	2003;	Gutiérrez	et	al.,	2013;	Hadi,	
Carr	&	Al	Suwaidi,	2005).	Therefore,	elucidating	the	mechanisms	
of	 aging‐associated	 ED	 development	 in	 more	 detail	 will	 help	 to	
prevent cardiovascular secondary diseases such as myocardial in‐
farction and stroke in the future.
Enhanced vascular permeability is a hallmark of ED (Bömmel 
et al., 2017; Ichiki et al., 2013; Phinikaridou et al., 2012). The 
carcinoembryonic	 antigen‐related	 cell	 adhesion	 molecule	 1	
(CEACAM1),	 a	 member	 of	 the	 immunoglobulin	 superfamily,	 is	
known	 to	 regulate	 vascular	 permeability	 (Nouvion	 et	 al.,	 2010).	
On	 the	one	hand,	CEACAM1	 is	an	 important	effector	of	VEGF/
VEGFR‐2	 signaling	 (Ergün	 et	 al.,	 2000)	 that	 is	 one	 of	 the	most	
potent inducers of vascular hyperpermeability (Bates, 2010). 
On	the	other	hand,	CEACAM1	was	shown	to	upregulate	the	en‐
dothelial	 expression	 of	 VEGF	 and	 VEGFR‐2	 (Kilic	 et	 al.,	 2005).	
Furthermore, we have previously shown that in the presence of 
TNF‐α,	 CEACAM1	 recruits	 Src	 kinase	 to	 intercellular	 adhesion	
sites, thereby promoting the phosphorylation of adherens junc‐
tion proteins and increasing vascular permeability (Ghavampour 
et al., 2018).
Based	 on	 these	 findings,	 we	 hypothesized	 that	 CEACAM1	
could	be	involved	in	age‐associated	ED	development.	However,	a	
role	 for	CEACAM1	 in	vascular	aging	has	not	been	proven	so	 far.	
Therefore, the aim of the present study was to elucidate the im‐
pact	of	CEACAM1	on	physiological	vascular	aging	with	respect	to	
the	initiation	of	age‐dependent	ED	by	analysis	of	human	and	mu‐
rine vascular specimens.
F I G U R E  1  Expression	of	
carcinoembryonic	antigen‐related	cell	
adhesion	molecule	1	(CEACAM1)	and	
VEGF	is	upregulated	in	aging	human	
vasculature. (a) Human internal thoracic 
artery	(HITA)	specimens	were	grouped	
according to age in three groups: <60, 60–
70 and >70 years. Immunohistochemical 
analyses	demonstrated	an	age‐dependent	
upregulation	of	CEACAM1	and	VEGF,	
especially within the intima. (b) Similar 
results were obtained by immunoblotting. 
The	transcription	factor	HIF‐1α that is 
involved	in	VEGF	gene	expression	was	
also	upregulated	with	advanced	age.	A,	
adventitia;	I,	intima;	M,	media
<60 years 60-70 years >70 years
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2  | RESULTS
2.1 | Lack of pathological alterations identify HITA 
as a suitable model of physiological vascular aging
Extensive	morphological	 analyses	 revealed	 that	human	 internal	 tho‐
racic	 artery	 (HITA)	 specimens	 display	 hardly	 any	 pathological	 al‐
terations such as atherosclerosis, intimal thickening, or inflammatory 
processes. Infiltration of inflammatory cells was detected only in one 
HITA	 sample	 (data	 not	 shown).	 Comparison	 of	HITA	 specimens	 ob‐
tained from patients of different age (Table S1) demonstrated that nor‐
mal vascular morphology was maintained even in advanced age (Figure 
S1a–d).	 In	some	HITA	specimens,	a	slight	 intimal	 thickening	was	ob‐
served	(Figure	1e,f).	However,	more	than	90%	of	HITA	specimens	did	
not show any vascular alterations. In comparison, 66% of radial artery 
specimens displayed vascular alterations such as intimal thickening or 
atherosclerotic	 plaque	 development	 (Figure	 1g,h).	 Therefore,	 HITA	
represents a suitable model to analyze physiological vascular aging.
F I G U R E  2  Expression	of	
carcinoembryonic	antigen‐related	
cell	adhesion	molecule	1	(CEACAM1),	
VEGF,	and	VEGFR‐2	is	age‐dependently	
upregulated in murine aortae. (a) 
Immunohistochemical staining of aortic 
cross	sections	derived	from	2‐	to	9‐
month‐old	mice.	Aortae	of	9‐month‐old	
mice showed a distinct upregulation 
of	CEACAM1,	VEGF,	and	VEGFR‐2	
compared	to	aortae	of	2‐month‐old	
mice.	(b)	Quantification	of	CEACAM1(+),	
VEGF(+),	and	VEGFR‐2(+)	cells	within	cross	
sections	of	2‐	and	9‐month‐old	mice.	Cell	
count was normalized to the inner aortic 
circumference. For all three proteins, the 
number of positive cells increased with 
age. (c) Immunohistochemical analyses 
of	aortic	cross	sections	of	9‐month‐old	
mice. Especially within the intima and 
adventitia,	a	high	number	of	cells	co‐
expressing	CEACAM1	with	VEGF	and	
VEGFR‐2,	respectively,	were	present.	A,	
adventitia;	I,	intima;	L,	lumen;	M,	media.	
*p < 0.05
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2.2 | Aging increases expression of CEACAM1, 
VEGF, and HIF‐1α in HITA
Carcinoembryonic	 antigen‐related	 cell	 adhesion	 molecule	 1	
regulates	endothelial	barrier	function	 in	an	age‐dependent	man‐
ner	 (Ghavampour	et	al.,	2018).	To	address	the	question	whether	
CEACAM1	 expression	 is	 altered	 in	 the	 course	 of	 physiological	
aging,	 HITA	 specimens	 grouped	 according	 to	 the	 donor's	 age	
(<60, 60–70, and >70 years) were analyzed immunohistochemi‐
cally (Figure 1a). These analyses showed a distinct upregulation 
of	CEACAM1	expression	within	the	intima	of	patients	aged	60–70	
and	 >70	 years.	 In	 contrast,	 CEACAM1	was	 hardly	 detectable	 in	
HITA	specimens	from	patients	younger	than	60	years.	Besides	the	
intima,	a	slight	CEACAM1	staining	could	be	detected	within	 the	
media that moderately increased with age (Figure 1a).
Carcinoembryonic	 antigen‐related	 cell	 adhesion	 molecule	 1	 is	
known	 to	 influence	VEGF/VEGFR‐2	 signaling	 (Ergün	 et	 al.,	 2004).	
According	to	the	results	obtained	for	CEACAM1,	immunohistochem‐
ical	analyses	of	HITA	specimens	revealed	a	concomitant	increase	in	
VEGF	expression	with	progressive	age,	especially	within	the	intima	
and media of the vascular wall (Figure 1a). Besides these findings, 
a	distinct	expression	of	CEACAM1	was	abundant	 in	vasa	vasorum	
only in patients older than 60 years (Figure 1i,j). Immunoblot anal‐
yses	confirmed	the	age‐dependent	upregulation	of	CEACAM1	and	
VEGF	(Figure	1b).
Since	 HIF‐1α	 induces	 expression	 of	 VEGF	 (Chen,	 Endler	 &	
Shibasaki,	2009),	HIF‐1α	 expression	was	analyzed	by	 immunoblot‐
ting.	Similar	to	VEGF,	HIF‐1α	is	upregulated	in	HITA	specimens	from	
older patients (Figure 1b).
2.3 | Aging increases expression of CEACAM1, 
VEGF, and VEGFR‐2 in murine aorta
In	order	to	dissect	the	role	of	CEACAM1	in	vascular	aging,	we	used	
a	murine	model	of	genetic	ablation	of	CEACAM1,	the	Cc1−/− mouse 
(Leung	et	al.,	2006;	Najjar	et	al.,	2013).
We	first	sought	to	verify	our	results	obtained	from	HITA	anal‐
yses in the murine model using animals aged 2–3 and 9 months, 
respectively.	Similar	to	HITA,	the	number	of	CEACAM1(+)	cells	and	
VEGF(+)	cells	within	the	aorta	increased	in	9‐month‐old	WT	mice	
compared	 to	 2‐month‐old	mice.	 In	 the	 case	 of	CEACAM1,	 aortic	
expression	 was	 undetectable	 in	 younger	 mice.	 Furthermore,	 we	
analyzed	 the	 presence	 of	 VEGFR‐2,	 the	 receptor	 that	 predomi‐
nantly	mediates	most	endothelial	VEGF	effects.	Similar	to	VEGF,	9‐
month‐old	WT	mice	showed	a	tremendous	increase	in	VEGFR‐2(+)	
cells	within	the	intima	(Figure	2a,b).	Altogether,	we	found	that	the	
age‐dependent	 alterations	 in	 the	 expression	 of	 CEACAM1	 and	
VEGF	observed	in	HITA	specimens	are	similarly	detectable	 in	the	
murine model. Therefore, we conclude that the murine model is 
suitable	to	investigate	the	contribution	of	CEACAM1	to	physiolog‐
ical vascular aging.
2.4 | CEACAM1 is involved in age‐dependent aortic 
expression of VEGF and VEGFR‐2
Since	 CEACAM1,	 VEGF,	 and	 VEGFR‐2	 showed	 a	 similar	 distribu‐
tion	 pattern	 in	 the	 aging	 vasculature,	 we	 conducted	 co‐immuno‐
histochemistry	 for	CEACAM1	 and	VEGF	or	VEGFR‐2	 in	 aortae	 of	
9‐month‐old	mice.	These	analyses	demonstrated	a	great	number	of	
F I G U R E  3   Carcinoembryonic 
antigen‐related	cell	adhesion	molecule	1	
(CEACAM1)	promotes	aortic	expression	of	
VEGF	and	VEGFR‐2	in	9‐month‐old	mice.	
(a)	CEACAM1	deficiency	resulted	in	a	
reduced	expression	of	VEGF	as	indicated	
by immunohistochemical analyses 
of murine aortic cross sections and 
immunoblotting, respectively. (b) Similar 
to	VEGF,	expression	of	VEGFR‐2	was	
lower in aortae of Cc1−/− compared to WT 
mice at the age of 9 months. *p < 0.05WT Cc1–/–
0
50
100
150
V
E
G
FR
-2
pr
ot
ei
n
(%
 o
fW
T) *
WT Cc1–/–
0
50
100
150
V
E
G
F 
pr
ot
ei
n
(%
 o
fW
T) *
(a) (b)
WT    Cc1–/–
VEGF
β-actin
WT    Cc1–/–
VEGFR-2
β-actin
WT Cc1-/- WT Cc1-/-
VEGF VEGFR-2
     |  5 of 13KLEEFELDT ET aL.
cells	co‐expressing	CEACAM1	with	VEGF	as	well	as	CEACAM1	with	
VEGFR‐2,	especially	within	the	intima	(Figure	2c).
In	order	to	analyze	the	contribution	of	CEACAM1	to	the	age‐de‐
pendent	alterations	in	aortic	VEGF	and	VEGFR‐2	expression,	aortae	
of	9‐month‐old	WT	and	Cc1−/− mice were analyzed by immunohisto‐
chemistry and immunoblotting. Using both methods, we found that 
aortic	expression	of	VEGF	is	higher	in	WT	mice	compared	to	Cc1−/− 
mice	 (Figure	3a).	 Similarly,	VEGFR‐2	expression	was	 also	higher	 in	
aortae of aged WT mice (Figure 3b).
2.5 | CEACAM1 contributes to age‐associated 
TNF‐α expression, oxidative stress, and 
stabilization of HIF‐1α
TNF‐α	expression	in	the	vasculature	increases	with	progressive	age	
in	 humans	 and	 rodents	 resulting	 in	 increasing	 vascular	 oxidative	
stress (Csiszar et al., 2003; Paolisso et al., 1998; Spaulding et al., 
1997;	 Zhang	 et	 al.,	 2009).	 In	 aortae	 of	 9‐month‐old	WT	mice,	we	
found	a	higher	number	of	TNF‐α(+)	cells	and	a	higher	TNF‐α	expres‐
sion compared to aortae of Cc1−/−	mice	(Figure	4a).	Vice	versa,	analy‐
sis	of	human	endothelial	EA.hy926	cells	demonstrated	an	induction	
of	CEACAM1	expression	upon	stimulation	with	TNF‐α, which was 
partially	inhibited	by	concomitant	application	of	the	NF‐κB inhibitor 
Bay	11‐7085	(Figure	4b).
TNF‐α	 is	known	to	promote	oxidative	stress	by	upregulation	of	
pro‐oxidative	 enzymes.	 Accordingly,	 we	 found	 a	 higher	 aortic	 ex‐
pression	of	the	NADPH	oxidase	subunit	NOX2	in	aortae	of	WT	mice	
compared to Cc1−/−	mice	 (Figure	4c).	4‐Hydroxy‐2,3‐trans‐nonenal	
(4‐HNE),	a	lipid	peroxidation	product,	is	frequently	used	as	a	stable	
marker	of	oxidative	 stress	 (Csala	et	al.,	2015).	 In	9‐month‐old	WT	
mice,	we	could	demonstrate	vascular	accumulation	of	4‐HNE	com‐
pared to Cc1−/− mice (Figure 4d).
F I G U R E  4   Carcinoembryonic 
antigen‐related	cell	adhesion	molecule	
1	(CEACAM1)	promotes	age‐dependent	
upregulation	of	TNF‐α	and	oxidative	
stress. (a) Immunohistochemical 
analyses of aortic cross sections and 
immunoblotting demonstrated that 
CEACAM1	promotes	age‐dependent	
upregulation	of	TNF‐α	in	9‐month‐old	
mice.	(b)	Vice	versa,	TNF‐α (50 ng/
ml,	72	hr)	upregulated	expression	of	
CEACAM1	in	cultured	endothelial	EA.
hy926	cells.	This	TNF‐α‐mediated	
upregulation	of	CEACAM1	was	partially	
attenuated by concomitant application of 
the	selective	NF‐κB	inhibitor	Bay	11‐7085	
(10 μM,	72	hr).	(c)	Aortic	mRNA	expression	
of	the	pro‐oxidative	NADPH	oxidase	
subunit	NOX2	was	significantly	higher	
in	9‐month‐old	WT	mice	when	compared	
to	age‐matched	Cc1−/−	mice.	(d)	4‐HNE,	a	
marker	of	oxidative	stress‐mediated	lipid	
peroxidation	accumulated	in	9‐month‐
old WT mice, but not in Cc1−/− mice, as 
demonstrated by immunohistochemical 
analyses of aortic cross sections. (e) 
Compared to Cc1−/− mice, the presence 
of	the	transcription	factor	HIF‐1α was 
increased	in	aortae	of	9‐month‐old	WT	
mice. *p < 0.05
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Oxidative	 stress	 is	 known	 to	 stabilize	HIF‐1α even under nor‐
moxic	 conditions	 (Kim	&	Byzova,	 2014;	 Sadaghianloo	 et	 al.,	 2017;	
Zhou	 et	 al.,	 2007).	 Accordingly,	 HIF‐1α protein was detectable in 
higher	amounts	in	aortae	of	9‐month‐old	WT	mice	compared	to	age‐
matched Cc1−/−	mice,	whereas	mRNA	expression	was	similar	indicat‐
ing protein stabilization (Figure 4e; Figure S2). Increased presence of 
TNF‐α,	4‐HNE,	and	HIF‐1α in the WT was predominantly confined to 
the intimal and adventitial aortic layers.
2.6 | Aging‐related upregulation of vascular 
CEACAM1 expression results in endothelial barrier 
dysfunction and promotes collagen accumulation
Progressive age is characterized by ED, which includes enhanced 
endothelial permeability (Bömmel et al., 2017; Ichiki et al., 2013; 
Phinikaridou	et	al.,	2012;	Rodríguez‐Mañas	et	al.,	2009).	Therefore,	
we	conducted	experiments	to	evaluate	endothelial	permeability	 in	
WT and Cc1−/− mice in situ. Perfusion of the murine circulation with 
an	Evans	Blue‐containing	solution	resulted	in	intimal	dye	deposition	
that is indicative of the endothelial permeability (Bömmel et al., 
2017).	 Intimal	 Evans	 Blue	 deposition	 was	 higher	 in	 aortae	 of	 9‐
month‐old	WT	mice	compared	to	Cc1−/− mice (Figure 5a).
Another	hallmark	of	vascular	aging	is	accumulation	of	collagen	
fibrils	with	subsequent	arterial	 fibrosis	 (Kohn,	Lampi	&	Reinhart‐
King, 2015). Therefore, picrosirius red staining of aortic cross 
sections was used to determine the aortic collagen content in 
WT and Cc1−/− mice, respectively. These analyses clearly demon‐
strated higher collagen content, especially within the aortic media 
of	 9‐month‐old	 WT	 mice	 compared	 to	 Cc1−/− mice (Figure 5b). 
Intriguingly,	 the	 collagen	 content	 of	 aortae	 from	 9‐month‐old	
Cc1−/−	mice	was	comparable	to	that	of	2‐month‐old	WT	and	Cc1−/− 
mice,	 respectively,	 indicating	 a	 complete	 lack	 of	 age‐associated	
aortic	 collagen	 deposition	 due	 to	 CEACAM1	 deficiency	 (Figure	
S3).	 TGF‐β/TGF‐βR1 signaling is known to stimulate collagen 
expression	 and	 deposition	 (Kim,	 Sheppard	 &	 Chapman,	 2018).	
Accordingly,	 expression	 of	 TGF‐β	 and	 TGF‐βR1 was higher in 
aortae	of	9‐month‐old	WT	mice	compared	to	age‐matched	Cc1−/− 
mice (Figure 5c; Figure S4).
F I G U R E  5   Carcinoembryonic 
antigen‐related	cell	adhesion	molecule	
1	(CEACAM1)	promotes	age‐dependent	
vascular hyperpermeability and aortic 
collagen	accumulation.	(a)	Aortic	cross	
sections	of	9‐month‐old	WT	and	Cc1−/− 
mice after in situ perfusion with an 
Evans	Blue‐containing	solution.	Aortic	
subendothelial dye deposition was 
higher in WT mice indicating increased 
endothelial permeability compared to 
Cc1−/− mice. (b) Detection of collagen by 
picrosirius red staining of aortic cross 
sections	from	9‐month‐old	WT	and	Cc1−/− 
mice.	In	the	presence	of	CEACAM1,	there	
was	a	distinct	age‐related	accumulation	
of collagen fibrils, especially within the 
aortic media. (c) Immunohistochemical 
analyses	of	the	expression	of	TGF‐β 
and	TGF‐βR1 in aortic cross sections 
of	9‐month‐old	WT	and	Cc1−/− mice. In 
WT	mice,	both	proteins	were	expressed	
higher	suggesting	augmented	pro‐fibrotic	
TGF‐β/TGF‐βR1 signaling in the presence 
of	CEACAM1.	*p < 0.05
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2.7 | Markers of inflammation, oxidative stress, and 
fibrosis are differentially expressed in 6‐ and 9‐
month‐old mice
In	aortae	of	9‐month‐old	mice,	we	found	that	markers	of	inflamma‐
tion,	 oxidative	 stress,	 and	 fibrosis	 are	more	 abundant	 in	WT	mice	
compared to Cc1−/− mice. This contrasts with a previous report on 
the	expression	of	those	markers	in	6‐month‐old	WT	and	Cc1−/− mice 
(Najjar	 et	 al.,	 2013).	 In	 order	 to	 verify	 our	 genetic	 mouse	 model,	
we	 re‐examined	 the	presence	of	TNF‐α,	4‐HNE,	and	TGF‐β in aor‐
tic	 cross	 sections	 from	6‐month‐old	WT	 and	Cc1−/− mice. In these 
immunohistochemical	analyses,	we	found	that	similar	to	Najjar	et	al.	
(2013), all three markers were more abundant in Cc1−/− mice (Figure 
S5).
2.8 | Aging‐associated vascular 
effects of CEACAM1 deficiency and TNF‐α are 
partially mimicked by CEACAM1 knockdown in 
endothelial cells
In	order	to	analyze	the	effect	of	CEACAM1	on	the	expression	of	fi‐
brosis‐,	oxidative	stress‐,	and	inflammation‐related	genes	under	basal	
F I G U R E  6   Knockdown of 
carcinoembryonic	antigen‐related	
cell	adhesion	molecule	1	(CEACAM1)	
in endothelial cells in vitro mimics in 
vivo	effects	of	CEACAM1	deficiency	
on	fibrosis‐,	oxidative	stress‐,	and	
inflammation‐related	genes.	(a)	
Immunoblot	detection	of	CEACAM1	
protein	in	control	siRNA	or	Cc1	siRNA‐
transfected	EA.hy926	cells	after	different	
time	points	and	upon	TNF‐α application. 
CEACAM1	protein	was	reduced	by	
approximately	50%	2–4	days	after	Cc1 
siRNA	transfection.	TNF‐α (50 ng/ml, 
72 hr) induced a huge upregulation of 
CEACAM1	protein	in	control	siRNA‐
transfected cells. However, even in the 
presence	of	TNF‐α, Cc1	siRNA	efficiently	
knocked	down	CEACAM1	protein.	(b)	
Analysis	of	mRNA	expression	under	
basal conditions 4 days after control and 
Cc1	siRNA	transfection,	respectively.	
Expression	of	TGF‐β,	TGF‐βR1,	and	NOX4	
was	significantly	higher	due	to	CEACAM1	
knockdown,	whereas	TNFR1	was	not	
affected.	TNF‐α was not detectable (n.d.) 
under	basal	conditions.	(c)	Analysis	of	
mRNA	expression	4	days	after	control	
and Cc1	siRNA	transfection,	respectively.	
One day after transfection, both groups 
of	cells	were	stimulated	with	TNF‐α 
(50 ng/ml) for the remaining 72 hr. The 
differences	in	the	expression	of	TGF‐β, 
TGF‐βR1,	and	NOX4	between	control	
and Cc1	siRNA‐transfected	cells	seen	
under	basal	conditions	were	equalized	by	
TNF‐α.	Again,	expression	of	TNFR1	was	
unaffected by the treatment. However, 
TNF‐α	induced	its	own	expression	in	
both groups of cells. This induction was 
much	more	pronounced	in	control	siRNA‐
transfected cells. *p < 0.05
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conditions	 and	 upon	 TNF‐α treatment in vitro, we knocked down 
CEACAM1	expression	in	EA.hy926	cells	using	the	siRNA	technique.	
CEACAM1	protein	expression	was	 reduced	by	approximately	50%	
2–4	days	after	transfection	of	cells	with	a	CEACAM1‐specific	siRNA	
when	compared	to	cells	transfected	with	a	CEACAM1‐unrelated	con‐
trol	siRNA	even	in	the	presence	of	TNF‐α (Figure 6a). Therefore, we 
analyzed	mRNA	expression	in	EA.hy926	cells	4	days	after	transfec‐
tion.	Under	basal	conditions,	mRNA	expression	of	TGF‐β,	TGF‐βR1, 
and	 NOX4	 was	 significantly	 increased	 by	 CEACAM1	 knockdown	
(Figure	6b).	TNFR1	was	not	affected	by	transfection	of	CEACAM1‐
specific	 siRNA,	 and	TNF‐α was not detectable under basal condi‐
tions	(Figure	6b).	TNF‐α treatment abolished the differences in the 
expression	of	TGF‐β,	TGF‐βR1,	and	NOX4	between	control	and	Cc1 
siRNA‐transfected	 cells	 that	 were	 present	 under	 basal	 conditions	
(Figure	6c).	Furthermore,	TNF‐α	induced	its	own	mRNA	expression	
in	 EA.hy926	 cells.	 This	 TNF‐α‐induced	 TNF‐α	 mRNA	 expression	
was	much	higher	in	cells	transfected	with	control	siRNA	(Figure	6c).	
Finally,	 mRNA	 expression	 of	 TNFR1	 was	 not	 different	 between	
TNF‐α‐treated	control	and	Cc1	siRNA‐transfected	cells	(Figure	6c).
3  | DISCUSSION
Cardiovascular diseases such as myocardial infarction and stroke are 
the leading cause of death worldwide (Gisterå & Hansson, 2017). 
In the last decades, cardiovascular research focused on pathological 
alterations,	 that	 is,	 atherosclerotic	 plaque	 formation	 using	 genetic	
mouse	models	(Gisterå	&	Hansson,	2017;	Lee	et	al.,	2016;	Whitman,	
2004). In contrast, the influence of physiological aging on the vas‐
culature and the triggers that cause transition into pathological con‐
ditions	are	 less	well	 examined	 (Wang	&	Bennett,	2012).	However,	
understanding vascular aging processes and the transition into an‐
giopathies is of great significance in order to develop therapeutic 
strategies to prevent myocardial infarction and stroke.
Carcinoembryonic	 antigen‐related	 cell	 adhesion	 molecule	 1	
is known to play a crucial role in the homeostasis of blood vessels 
(Ghavampour	et	al.,	2018;	Najjar	et	al.,	2013).	In	the	present	study,	
we	 prove	 for	 the	 first	 time	 a	 role	 of	 CEACAM1	 in	 vascular	 aging	
processes	in	mice	and	humans.	In	brief,	we	show	that:	(a)	HITA	rep‐
resents a suitable model to investigate physiological vascular aging; 
(b)	with	increasing	age,	TNF‐α	induces	CEACAM1	expression,	which	
in	turn	upregulates	TNF‐α,	thus	maintaining	a	pro‐inflammatory	mi‐
lieu;	 (c)	this	results	 in	enhanced	oxidative	stress	stabilizing	HIF‐1α; 
(d)	HIF‐1α	contributes	to	endothelial	barrier	 impairment	via	VEGF/
VEGFR‐2	signaling;	and	(e)	CEACAM1	contributes	to	age‐dependent	
vascular	fibrosis	via	augmented	TGF‐β/TGF‐βR1 signaling.
Investigation of physiological vascular aging in humans is diffi‐
cult due to limited availability of human tissue samples (Wang et al., 
2007).	In	the	present	study,	we	made	use	of	HITA	specimens	for	two	
reasons.	First,	HITA	is	the	preferred	vessel	for	human	coronary	by‐
pass	graft	surgery	due	to	its	superior	long‐term	patency	compared	to	
other	vessel	grafts	(King,	2011;	Otsuka,	Yahagi,	Sakakura	&	Virmani,	
2013).	 Therefore,	 surplus	 fragments	 of	 HITA	 that	 are	 cut	 during	
aortocoronary bypass surgery are accessible for further analyses. 
Second,	 in	 order	 to	 study	 physiological	 age‐associated	 processes,	
the samples should be as free as possible from pathological alter‐
ations.	HITA	is	well	known	for	its	resistance	against	atherosclerotic	
plaque	formation	(Singh,	1983).	In	our	study,	we	confirmed	this	mor‐
phological	stability	of	HITA	in	comparison	with	radial	artery	speci‐
mens.	HITA	specimens	displayed	almost	no	pathological	alterations	
such as inflammatory cell accumulation, intimal thickening, or ath‐
erosclerotic	plaque	 formation	compared	 to	 radial	 arteries,	 even	at	
advanced	age.	These	findings	further	support	the	suitability	of	HITA	
to study physiological vascular aging in humans.
Vascular	 aging	 is	 accompanied	 by	 the	 development	 of	 ED	
(Rodríguez‐Mañas	et	al.,	2009),	which	 is,	among	others,	character‐
ized by enhanced vascular permeability (Bömmel et al., 2017; Ichiki 
et al., 2013; Phinikaridou et al., 2012). Recently, we showed that 
CEACAM1	contributes	 to	an	 increased	endothelial	permeability	 in	
9‐month‐old	mice	 (Ghavampour	 et	 al.,	 2018).	 Therefore,	we	won‐
dered	whether	CEACAM1	expression	is	age‐dependently	regulated.	
Analyzing	HITA	specimens	from	patients	of	different	age,	we	found	
that	expression	of	CEACAM1	is	higher	in	older	donors.	Interestingly,	
expression	of	VEGF	and	the	transcription	factor	HIF‐1α that medi‐
ates	VEGF	 transcription	 in	 response	 to	hypoxia	were	 similarly	up‐
regulated	in	HITA	from	older	donors.	VEGF	is	a	potent	mediator	of	
endothelial	permeability	(Bates,	2010)	that	is	induced	by	CEACAM1	
overexpression	(Kilic	et	al.,	2005).	Therefore,	it	is	feasible	to	specu‐
late	that	CEACAM1	is	responsible	for	the	vascular	upregulation	of	
VEGF	in	older	donors.	Unfortunately,	a	causal	relationship	between	
CEACAM1	and	VEGF	upregulation	cannot	be	tested	using	the	HITA	
model.
To	 answer	 that	 question,	 we	 used	 a	 murine	 model	 of	 genetic	
ablation	of	CEACAM1,	the	Cc1−/−	mouse	(Leung	et	al.,	2006;	Najjar	
et	al.,	2013).	We	analyzed	2‐month‐old	mice	compared	to	9‐month‐
old	mice.	At	9	months,	mice	 represent	middle‐aged	mature	 adults	
(Fox	et	al.,	2007),	a	phase	of	life	known	to	be	associated	with	first	
pathological vascular alterations in humans (Tuzcu et al., 2001). First, 
we	verified	the	suitability	of	the	murine	model.	Similar	to	HITA,	we	
detected	an	upregulation	of	CEACAM1	and	VEGF	in	the	aortae	of	
the	older	group.	Additionally,	aortic	VEGFR‐2	expression	was	higher	
in	 9‐month‐old	 mice,	 further	 supporting	 the	 assumption	 of	 aug‐
mented	vascular	VEGF	signaling	with	increasing	age.
The	 first	 hint	 for	 an	 involvement	 of	 CEACAM1	 in	 age‐asso‐
ciated	 increased	 VEGF	 signaling	 came	 from	 co‐immunohisto‐
chemical	analyses	of	aortae	from	9‐month‐old	WT	mice.	In	these	
samples,	 an	 extensive	 co‐localization	 of	 CEACAM1	 with	 VEGF	
and	VEGFR‐2,	 respectively,	was	detected.	More	 importantly,	we	
found	 that	 the	number	of	VEGF(+)	 and	VEGFR‐2(+)	 cells,	 as	well	
as	 protein	 expression	 of	VEGF	 and	VEGFR‐2,	was	 tremendously	
reduced	in	aortae	of	9‐month‐old	Cc1−/− mice. This clearly proves 
a	 crucial	 role	 of	 CEACAM1	 for	 the	 age‐dependent	 upregulation	
of	VEGF	and	VEGFR‐2	expression	and	confirms	to	a	previous	re‐
port	showing	CEACAM1‐mediated	VEGF	expression	in	endothelial	
cells	 (Kilic	et	al.,	2005).	Since	VEGF/VEGFR‐2	signaling	 is	one	of	
the most potent inducers of vascular hyperpermeability (Bates, 
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2010),	it	is	not	surprising	that	CEACAM1	also	affects	endothelial	
permeability	in	9‐month‐old	mice.	Compared	to	Cc1−/− mice, inti‐
mal Evans Blue deposition as a marker of endothelial permeability 
was much higher in aortae from WT mice.
Next,	we	aimed	to	elucidate	 the	mechanism	that	was	respon‐
sible	 for	 CEACAM1‐dependent	 aortic	 VEGF/VEGFR‐2	 upregula‐
tion	and	increased	vascular	permeability	in	9‐month‐old	WT	mice.	
Vascular	expression	and	circulating	levels	of	TNF‐α,	a	potent	pro‐
inflammatory peptide, are increased in aging rodents and humans 
(Csiszar et al., 2003; Paolisso et al., 1998; Spaulding et al., 1997). 
Therefore, it represents an attractive candidate for mediating 
age‐dependent	vascular	alterations,	that	is,	via	increased	oxidative	
stress	(Chen	et	al.,	2008;	Rodríguez‐Mañas	et	al.,	2009).	Using	our	
murine	model,	 we	 demonstrated	 that	 the	 vascular	 expression	 of	
TNF‐α	 in	9‐month‐old	mice	critically	depends	on	the	presence	of	
CEACAM1.	This	conclusion	is	further	supported	by	our	finding	that	
the	 TNF‐α‐induced	 TNF‐α	 expression	 is	 impaired	 in	 endothelial	
cells	with	 CEACAM1‐specific	 knockdown.	Moreover,	 we	 showed	
that	TNF‐α	 robustly	 induces	 the	 expression	of	CEACAM1	 in	 cul‐
tured	human	endothelial	cells,	an	effect	partially	mediated	by	NF‐
κB activation. Based on these data, we assume that in the aging 
vasculature, a vicious cycle is established by mutual upregulation 
of	CEACAM1	and	TNF‐α	expression	that	contributes	to	the	mainte‐
nance	of	a	pro‐inflammatory	milieu	(Gisterå	&	Hansson,	2017;	Wu,	
Li,	Hou,	&	Chu,	2017).
TNF‐α	was	shown	to	promote	formation	of	reactive	oxygen	spe‐
cies,	that	is,	by	upregulation	of	vascular	NADPH	oxidases	(Moe	et	al.,	
2006;	Muzaffar,	 Shukla,	Angelini	&	 Jeremy,	 2004).	Accordingly,	 in	
aortae	of	9‐month‐old	WT	mice	expression	of	the	NADPH	oxidase	
subunit	 NOX2	 was	 higher	 compared	 to	 Cc1−/−	 mice.	 Additionally,	
4‐HNE,	 a	 stable	 lipid	 peroxidation	 product	 indicative	 of	 oxidative	
stress,	was	more	abundant	in	aortae	of	WT	mice.	Increased	oxidative	
stress	in	9‐month‐old	WT	mice	is	of	special	interest,	because	it	was	
shown	that	oxidative	stress	stabilizes	HIF‐1α	even	under	normoxic	
conditions (Kim & Byzova, 2014; Sadaghianloo et al., 2017; Zhou 
et	al.,	2007)	and	HIF‐1α	mediates	VEGF	gene	transcription	(Shibuya,	
2011).	Indeed,	the	presence	of	HIF‐1α protein was higher in aortae 
of	9‐month‐old	WT	mice	compared	to	Cc1−/−	mice,	whereas	mRNA	
expression	was	not	different.	This	supports	the	conclusion	of	a	sta‐
bilization	of	HIF‐1α	protein	 in	9‐month‐old	WT	mice.	Since	HIF‐1α 
activity	 was	 shown	 to	 promote	 also	 NOX2	 expression	 (Diebold	
et al., 2012), the establishment of a vicious cycle augmenting vascu‐
lar inflammation in aged vessels can be assumed. Summarizing these 
data,	we	found	evidence	that	in	the	aging	murine	aorta,	CEACAM1	
contributes	 to	 an	 upregulation	 of	 TNF‐α,	which	 stimulates	VEGF/
VEGFR‐2	signaling	via	oxidative	stress‐mediated	HIF‐1α stabilization, 
thereby promoting increased endothelial permeability. In addition, 
we	showed	previously	 that	on	 the	 cellular	 and	organ	 level,	 TNF‐α 
increases	endothelial	permeability	in	the	presence	of	CEACAM1,	but	
reduces	 it	 in	the	absence	of	CEACAM1	(Ghavampour	et	al.,	2018).	
This	differential	TNF‐α‐mediated	effect	could	also	contribute	to	the	
increased	permeability	 in	9‐month‐old	WT	mice	compared	to	age‐
matched Cc1−/− mice.
Increased	endothelial	 permeability	 is	 characteristic	of	 age‐as‐
sociated ED. Beside these functional alterations, fragmentation of 
elastic fibers and deposition of less compliant collagen fibers lead‐
ing to vascular fibrosis accompany vascular aging (Wang & Bennett, 
2012).	Those	structural	age‐dependent	alterations	seem	to	depend	
on	CEACAM1,	 too.	Whereas	 in	9‐month‐old	WT	mice,	a	 tremen‐
dous deposition of collagen, especially within the aortic media is 
detectable,	 aortic	 media	 of	 age‐matched	 Cc1−/− mice are almost 
free of collagen. Thus, concerning collagen deposition, aortae of 
9‐month‐old	 Cc1−/−	 mice	 are	 indistinguishable	 from	 those	 of	 2‐
month‐old	WT	and	Cc1−/−	mice,	respectively.	TGF‐β/TGF‐βR1 sig‐
naling is an important factor promoting tissue collagen deposition 
(Kim	et	al.,	2018).	Since	expression	of	TGF‐β	and	TGF‐βR1 is signifi‐
cantly	lower	in	aortae	of	9‐month‐old	Cc1−/− mice compared to WT 
mice,	reduced	TGF‐β/TGF‐βR1 signaling may be responsible for the 
lack	of	age‐associated	collagen	deposition	in	CEACAM1	deficiency.
In an attempt to strengthen the conclusions drawn from the 
in vivo data, we established an endothelial cell culture model. 
Transfection	 of	 EA.hy926	 cells	with	 CEACAM1‐specific	 siRNA	 re‐
duced	 CEACAM1	 protein	 expression	 by	 approximately	 50%.	 The	
reduced	abundance	of	CEACAM1	resulted	 in	an	 increased	expres‐
sion	of	the	pro‐fibrotic	genes	TGF‐β	and	TGF‐βR1. Furthermore, the 
NADPH	oxidase	subunit	NOX4	was	upregulated.	At	first	glance,	these	
data	seem	to	contradict	our	results	from	9‐month‐old	mice	showing	
a	reduced	presence	of	TGF‐β,	TGF‐βR1,	and	oxidative	stress	marker	
within	the	aortic	wall	due	to	CEACAM1	deficiency.	However,	these	
data	conform	to	 results	of	a	 study	on	6‐month‐old	WT	and	Cc1−/− 
mice	published	by	Najjar	et	al.	(2013).	Upregulation	of	inflammatory	
and	pro‐oxidative	markers	in	6‐month‐old	Cc1−/− mice was ascribed 
to	hyperinsulinemia	due	to	reduced	hepatic	insulin	clearance	(Najjar	
et	al.,	2013).	However,	our	results	obtained	from	cultured	EA.hy926	
support	 a	 rather	 endothelial	 cell‐autonomous	 effect	 of	CEACAM1	
deficiency	on	the	expression	of	TGF‐β1	and	NOX4.	With	respect	to	
TNF‐α, systemic factors, that is, hyperinsulinemia, might trigger the 
increased	arterial	presence	of	this	pro‐inflammatory	cytokine	 in	6‐
month‐old	Cc1−/− mice as suggested, since we were unable to detect 
TNF‐α in our cultured endothelial cells under basal conditions. This 
demonstrates that under basal conditions, our cell culture model re‐
produces the situation in WT and Cc1−/− mice at a younger stage.
With	advancing	age,	 circulating	 levels	 as	well	 as	 vascular	 ex‐
pression	 of	 TNF‐α increase (Csiszar et al., 2003; Paolisso et al., 
1998; Spaulding et al., 1997). The actual trigger of this process is 
unknown.	We	aimed	to	mimic	this	situation	in	vitro	by	TNF‐α treat‐
ment of control and Cc1	siRNA‐transfected	EA.hy926	cells.	Upon	
treatment	with	TNF‐α,	the	CEACAM1‐mediated	differences	in	the	
expression	 of	 TGF‐β,	 TGF‐βR1,	 and	NOX4	 detected	 under	 basal	
conditions	 were	 equalized.	 Hence,	 TNF‐α application induced a 
trend	toward	the	aortic	expression	ratios	detected	in	9‐month‐old	
WT and Cc1−/−	mice.	 In	vivo,	 the	effect	of	TNF‐α might be much 
more pronounced in WT mice, because our endothelial cell culture 
experiments	 demonstrate	 an	 upregulation	 of	CEACAM1	expres‐
sion	by	TNF‐α	 and,	 in	 turn,	 an	augmented	TNF‐α‐induced	endo‐
thelial	TNF‐α	expression	in	the	presence	of	CEACAM1.	Therefore,	
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these	 data	 suggest	 an	 amplification	 of	 TNF‐α‐mediated	 age‐re‐
lated effects that takes place in WT but is absent in Cc1−/− mice 
resulting	in	a	switch	in	the	vascular	expression	profile	of	WT	and	
Cc1−/− mice between 6 and 9 months of age.
In	summary,	we	clearly	show	that	CEACAM1	contributes	to	dif‐
ferent structural and functional aspects of vascular aging. Some of 
these	 CEACAM1‐dependent	 effects,	 that	 is,	 increased	 oxidative	
stress,	increased	VEGF/VEGFR‐2	signaling,	and	increased	endothe‐
lial permeability, may render aged blood vessels prone to the onset 
of vascular disorders such as atherosclerosis in the presence of ad‐
ditional	risk	factors	 (Figure	7).	Therefore,	CEACAM1	function	may	
represent	 a	potential	 target	 in	order	 to	delay	unfavorable	 age‐de‐
pendent vascular alterations, thereby preventing the onset of transi‐
tion from physiological aging into angiopathies with their secondary 
diseases such as myocardial infarction and stroke.
4  | E XPERIMENTAL PROCEDURES
4.1 | Animals
Cc1−/−	mice	(Leung	et	al.,	2006;	Najjar	et	al.,	2013)	and	their	WT	lit‐
termates	(C57BL/6J;	The	Jackson	Laboratory)	were	housed	in	spe‐
cific	pathogen‐free	conditions	on	a	12:12‐hour	dark–light	cycle	and	
fed	standard	chow	ad	 libitum.	Mice	were	analyzed	at	 the	age	of	2	
and	9	months,	respectively.	All	animal	experiments	were	approved	
by local authorities (Regierung von Unterfranken) to comply with 
German animal protection law.
4.2 | Human tissue samples
Human internal thoracic artery fragments were obtained dur‐
ing aortocoronary bypass surgery in the Clinics of Thoracic and 
Cardiovascular Surgery, University Hospital Essen, without additional 
burden for the patients according to local ethical and biohazard regu‐
lations.	All	studies	analyzing	human	tissue	samples	were	approved	by	
the	local	ethics	committee.	Informed	consent	form	(Nr.	10‐4363)	was	
provided	by	the	ethics	commission	of	the	University	Medical	Faculty	
Essen.	HITA	fragments	were	grouped	according	to	patients’	age	into	
three groups: <60, 60–70, and >70 years based on preliminary results.
4.3 | Cell culture
Endothelial	 EA.hy926	 cells	 (ATCC®	 CRL‐2922™;	 ATCC,	 LGC	
Standards	 GmbH)	 were	 cultured	 in	 DMEM/10%	 FCS	 (Thermo	
Fisher; Biochrom GmbH) at 37°C/5% CO2.	For	 stimulation	experi‐
ments,	cells	were	 incubated	with	50	ng/ml	TNF‐α (Thermo Fisher) 
for	72	hr.	Bay	11‐7085	(Cayman	Chemical;	10	μM)	was	used	to	inhibit	
NF‐κB activation.
4.4 | CEACAM1 knockdown
Carcinoembryonic	antigen‐related	cell	adhesion	molecule	1	protein	
expression	was	knocked	down	 in	endothelial	EA.hy926	cells	using	
a	 siRNA	specific	 for	human	Cc1	 (CEACAM1	siRNA	 (h);	Santa	Cruz	
Biotechnology).	 An	 unrelated	 siRNA	 served	 as	 control	 (Control	
siRNA‐A;	Santa	Cruz	Biotechnology).	Transfection	of	cells	with	siR‐
NAs	was	carried	out	using	siRNA	Transfection	Reagent	and	siRNA	
Transfection	Medium	according	to	the	manufacturer's	 instructions	
(8 μl scale; Santa Cruz Biotechnology). The knockdown effect was 
monitored	up	to	6	days.	CEACAM1	protein	expression	was	reduced	
by	approximately	50%	2–4	days	after	transfection	of	cells.
4.5 | Immunohistochemistry, immunoblotting, and 
cell count analysis
Immunohistochemical analyses were conducted as described 
previously (Ergün et al., 2004; Ghavampour et al., 2018). The im‐
munoreaction	 was	 detected	 using	 peroxidase–antiperoxidase	 and	
avidin–biotin	 complex	 methods	 by	 a	 modified	 nickel‐enhanced	
F I G U R E  7  Carcinoembryonic	antigen‐related	cell	adhesion	
molecule	1	(CEACAM1)	as	a	central	mediator	of	vascular	aging.	In	
the	course	of	vascular	aging,	CEACAM1	expression	is	increased.	
CEACAM1	promotes	aortic	upregulation	of	the	pro‐inflammatory	
cytokine	TNF‐α that, in turn, further contributes to an enhanced 
CEACAM1	expression.	This	mutual	influence	establishes	a	feed‐
forward	loop	maintaining	a	chronic	pro‐inflammatory	milieu	
within	the	vessel	wall.	Upregulated	TNF‐α	may	induce	expression	
of	pro‐oxidative	enzymes,	that	is,	NOX2,	that	contribute	to	an	
oxidative	stress‐mediated	stabilization	of	HIF‐1α.	HIF‐1α that 
induces	VEGF/VEGFR‐2	signaling	thus	promotes	endothelial	
hyperpermeability of aged vessels. Beside this pathway leading to 
age‐related	endothelial	dysfunction,	upregulated	TNF‐α may also 
account	for	the	age‐dependently	increased	arterial	fibrosis	via	
enhanced	TGF‐β/TGF‐βR1 signaling. In the presence of additional 
risk	factors,	these	CEACAM1‐mediated	age‐dependent	vascular	
alterations may transform into the development of vascular 
disorders, that is, atherosclerosis
Plaque
formation
VEGF/
VEGFR-2
TGF-β/
TGF-βR1
Aging
CEACAM1
TNF-α
Endothelial
dysfunction
Additional
risk factors
NOX2/4
HIF-1α
ROS
Arterial
fibrosis
NF-κB
     |  11 of 13KLEEFELDT ET aL.
glucose	 oxidase	 technique	 (Kilic	 &	 Ergün,	 2001).	 Immunoblot	 ex‐
periments were conducted according to a protocol described before 
(Ghavampour	et	al.,	2018;	Oliveira‐Ferrer	et	al.,	2004).	Primary	an‐
tibodies used in this study are listed in Table S2. Secondary anti‐
bodies used for immunohistochemical or immunoblot analyses were 
provided	 by	 Dako	 (Agilent)	 and	 Pierce	 (Thermo	 Fisher	 Scientific),	
respectively.
Cell counts of immunostained intimal and medial cells and en‐
dothelial	 circumference	 were	 determined	 using	 ImageJ	 software	
(Wayne	Rasband,	NIH1.46r)	as	described	before	(Jensen,	2013).	Cell	
counts of immunostained cells were normalized to the endothelial 
circumference of the respective aortic cross section.
4.6 | Picrosirius red staining
Picrosirius red staining was performed according to a protocol de‐
scribed	previously	(Vogel,	Siebert,	Hofmann	&	Frantz,	2015).	After	
de‐waxing	and	hydration,	paraffin‐embedded	 tissue	sections	were	
stained	with	Weigert's	hematoxylin.	Collagen	fibers	within	the	tissue	
samples were stained for 1 hr using 1% Direct Red 80 in saturated 
aqueous	 solution	 of	 picric	 acid	 (both	 from	 Sigma‐Aldrich).	 Tissue	
sections were washed twice with acidified water and were dehy‐
drated	using	ethanol	 solutions.	 ImageJ	 software	 (Wayne	Rasband,	
NIH1.46r)	was	used	to	quantify	the	collagen	content	that	was	nor‐
malized to the endothelial circumference.
4.7 | Permeability assay
Vascular	 permeability	 assays	 were	 performed	 as	 described	 pre‐
viously (Bömmel et al., 2017). Briefly, after cervical dislocation 
blood was removed by flushing the circulation with Ringer solu‐
tion through the left ventricle. Thereafter, vasculature of mice was 
perfused with the dye Evans Blue (0.03% in Ringer solution, color 
index	number:	23,860;	Sigma‐Aldrich).	Depending	on	the	vascular	
permeability, Evans Blue was able to diffuse into the subendothe‐
lial	compartment	of	blood	vessels.	After	30	min,	the	remaining	in‐
travascular	dye	was	washed	away	using	PBS.	Aortae	were	 freed	
from	perivascular	fat,	dissected	out,	and	fixed	with	4%	PFA	for	1	hr.	
After	washing	with	PBS,	the	thoracic	aorta	was	frozen	in	Tissue‐
Tek®	(Sakura	Finetek	Europe	B.W.,	NL).	Ten	micrometer	cross‐cry‐
osections	 were	 prepared	 and	 subsequently	 counterstained	with	
calcium	 red	 (Sigma‐Aldrich).	 Images	were	 taken	 from	at	 least	 10	
randomly selected sections using a Keyence BZ9000 microscope 
(Keyence).	ImageJ	software	(Wayne	Rasband,	NIH1.46r)	was	used	
to determine the portion of the intima that was stained by Evans 
Blue	in	these	sections.	The	dye‐stained	length	normalized	to	the	
total intimal circumference was used as a marker of endothelial 
permeability.
4.8 | Quantitative real‐time PCR
After	 isolation	 of	 total	 RNA	 (Qiazol;	 Qiagen	 Sciences	 Inc)	 and	
DNase	 I	 treatment	 (Promega),	 RNA	 was	 transcribed	 into	 cDNA	
(SuperScript	II;	Thermo	Fisher	Scientific).	For	each	sample,	mRNA	
expression	 was	 analyzed	 by	 real‐time	 PCR	 in	 triplicate	 (GoTaq	
qPCR	Master	Mix;	Promega).	Carryover	of	genomic	DNA	was	mon‐
itored	by	running	an	amplification	with	SuperScript	II‐deficient	RT	
reaction as template for each sample. Primers used in this study 
(Eurofins	Genomics)	are	listed	in	Table	S3.	After	completion	of	the	
PCR cycling protocol (95°C for 30 s; 60°C for 30 s; 72°C for 30 s; 
40×), specificity of amplification was proven by melting curve anal‐
yses.	Values	for	the	mRNA	of	the	respective	genes	were	normal‐
ized	to	glyceraldehyde‐3‐phosphate	dehydrogenase	mRNA	and	are	
given	as	arbitrary	units	(a.u.)	or	as	percent	of	control	siRNA.
4.9 | Statistical analyses
All	experiments	were	repeated	at	least	three	times	with	similar	re‐
sults. Data are presented as mean ± sem and were compared using 
two‐tailed	 Student's	 t	 test	 or	 analysis	 of	 variance	 (ANOVA)	when	
appropriate. The null hypothesis was rejected at p < .05 (*).p < .001 
was considered highly significant (***).
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